119 related articles for article (PubMed ID: 35679834)
21. Potential of Targeting TDO2 as the Lung Adenocarcinoma Treatment.
Jin E; Yin Z; Zheng X; Yan C; Xu K; Eunice FY; Gao Y
J Proteome Res; 2024 Apr; 23(4):1341-1350. PubMed ID: 38421152
[TBL] [Abstract][Full Text] [Related]
22. Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening.
Sari S; Tomek P; Leung E; Reynisson J
Molecules; 2019 Nov; 24(23):. PubMed ID: 31795096
[TBL] [Abstract][Full Text] [Related]
23. Association of PD-L1 and IDO1 expression with JAK-STAT pathway activation in soft-tissue leiomyosarcoma.
Iwasaki T; Kohashi K; Toda Y; Ishihara S; Yamada Y; Oda Y
J Cancer Res Clin Oncol; 2021 May; 147(5):1451-1463. PubMed ID: 32951108
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive behavioral analysis of tryptophan 2,3-dioxygenase (Tdo2) knockout mice.
Hattori S; Takao K; Funakoshi H; Miyakawa T
Neuropsychopharmacol Rep; 2018 Jun; 38(2):52-60. PubMed ID: 30106261
[TBL] [Abstract][Full Text] [Related]
25. Gene expression of indoleamine and tryptophan dioxygenases and three long non-coding RNAs in breast cancer.
Ghafouri-Fard S; Taherian-Esfahani Z; Dashti S; Kholghi Oskooei V; Taheri M; Samsami M
Exp Mol Pathol; 2020 Jun; 114():104415. PubMed ID: 32165090
[TBL] [Abstract][Full Text] [Related]
26. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.
D'Amato NC; Rogers TJ; Gordon MA; Greene LI; Cochrane DR; Spoelstra NS; Nemkov TG; D'Alessandro A; Hansen KC; Richer JK
Cancer Res; 2015 Nov; 75(21):4651-64. PubMed ID: 26363006
[TBL] [Abstract][Full Text] [Related]
27. The Tobacco β-Cembrenediol: A Prostate Cancer Recurrence Suppressor Lead and Prospective Scaffold via Modulation of Indoleamine 2,3-Dioxygenase and Tryptophan Dioxygenase.
Mudhish EA; Siddique AB; Ebrahim HY; Abdelwahed KS; King JA; El Sayed KA
Nutrients; 2022 Apr; 14(7):. PubMed ID: 35406118
[TBL] [Abstract][Full Text] [Related]
28. Circular RNA circZNF566 promotes hepatocellular carcinoma progression by sponging miR-4738-3p and regulating TDO2 expression.
Li S; Weng J; Song F; Li L; Xiao C; Yang W; Xu J
Cell Death Dis; 2020 Jun; 11(6):452. PubMed ID: 32532962
[TBL] [Abstract][Full Text] [Related]
29. Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function.
Too LK; Li KM; Suarna C; Maghzal GJ; Stocker R; McGregor IS; Hunt NH
Behav Brain Res; 2016 Oct; 312():102-17. PubMed ID: 27316339
[TBL] [Abstract][Full Text] [Related]
30. Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.
Cheong JE; Sun L
Trends Pharmacol Sci; 2018 Mar; 39(3):307-325. PubMed ID: 29254698
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia Inducible Factor 1α Inhibits the Expression of Immunosuppressive Tryptophan-2,3-Dioxygenase in Glioblastoma.
Mohapatra SR; Sadik A; Tykocinski LO; Dietze J; Poschet G; Heiland I; Opitz CA
Front Immunol; 2019; 10():2762. PubMed ID: 31866995
[TBL] [Abstract][Full Text] [Related]
32. Tryptophan metabolism enzymes are potential targets in ovarian clear cell carcinoma.
Zhang S; Gao Y; Wang P; Wang S; Wang Y; Li M; Wang A; Zhao K; Zhang Z; Sun J; Guo D; Liang Z
Cancer Med; 2023 Dec; 12(24):21996-22005. PubMed ID: 38062922
[TBL] [Abstract][Full Text] [Related]
33. Expression Pattern and Clinicopathological Relevance of the Indoleamine 2,3-Dioxygenase 1/Tryptophan 2,3-Dioxygenase Protein in Colorectal Cancer.
Chen IC; Lee KH; Hsu YH; Wang WR; Chen CM; Cheng YW
Dis Markers; 2016; 2016():8169724. PubMed ID: 27578919
[TBL] [Abstract][Full Text] [Related]
34. A cohort study using IL-6/Stat3 activity and PD-1/PD-L1 expression to predict five-year survival for patients after gastric cancer resection.
Li XN; Peng YH; Yue W; Tao L; Zhang WJ
PLoS One; 2022; 17(12):e0277908. PubMed ID: 36454780
[TBL] [Abstract][Full Text] [Related]
35. TDO2 Was Downregulated in Hepatocellular Carcinoma and Inhibited Cell Proliferation by Upregulating the Expression of p21 and p27.
Yu C; Rao D; Zhu H; Liu Q; Huang W; Zhang L; Liang H; Song J; Ding Z
Biomed Res Int; 2021; 2021():4708439. PubMed ID: 34423034
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer.
Ito S; Masuda T; Noda M; Hu Q; Shimizu D; Kuroda Y; Eguchi H; Tobo T; Utsunomiya T; Mimori K
Oncology; 2020; 98(7):501-511. PubMed ID: 32380498
[TBL] [Abstract][Full Text] [Related]
37. A comprehensive analysis of TDO2 expression in immune cells and characterization of immune cell phenotype in TDO2 knockout mice.
Li S; Li S; Zhao Y; Zhang B; Wang X; Yang X; Wang Y; Jia C; Chang Y; Wei W
Transgenic Res; 2021 Dec; 30(6):781-797. PubMed ID: 34529208
[TBL] [Abstract][Full Text] [Related]
38. Tryptophan 2,3-dioxygenase 2 plays a key role in regulating the activation of fibroblast-like synoviocytes in autoimmune arthritis.
Chang Y; Han P; Wang Y; Jia C; Zhang B; Zhao Y; Li S; Li S; Wang X; Yang X; Wei W
Br J Pharmacol; 2022 Jun; 179(12):3024-3042. PubMed ID: 34969166
[TBL] [Abstract][Full Text] [Related]
39. Constitutive TDO2 expression promotes liver cancer progression by an autocrine IL-6 signaling pathway.
Wu Z; Yan L; Lin J; Ke K; Yang W
Cancer Cell Int; 2021 Oct; 21(1):538. PubMed ID: 34657635
[TBL] [Abstract][Full Text] [Related]
40. Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib.
Riess C; Schneider B; Kehnscherper H; Gesche J; Irmscher N; Shokraie F; Classen CF; Wirthgen E; Domanska G; Zimpfer A; Strüder D; Junghanss C; Maletzki C
Front Immunol; 2020; 11():55. PubMed ID: 32117235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]